Citation: | Zexuan Hong, Jun Cao, Dandan Liu, Maozhu Liu, Mengyuan Chen, Fanning Zeng, Zaisheng Qin, Jigang Wang, Tao Tao. Celastrol targeting Nedd4 reduces Nrf2-mediated oxidative stress in astrocytes after ischemic stroke[J]. Journal of Pharmaceutical Analysis, 2023, 13(2): 156-169. doi: 10.1016/j.jpha.2022.12.002 |
GBD 2019 Stroke Collaborators, Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019, Lancet Neurol. 20 (2021) 795-820
|
D. Kuriakose, Z. Xiao, Pathophysiology and treatment of stroke: present status and future perspectives, Int. J. Mol. Sci. 21 (2020), 7609
|
M.-S. Sun, H. Jin, X. Sun, et al., Free radical damage in ischemia-reperfusion injury: An obstacle in acute ischemic stroke after revascularization therapy, Oxid. Med. Cell. Longev. 2018 (2018), 3804979
|
K. Lin, Z. Zhang, Z. Zhang, et al., Oleanolic acid alleviates cerebral ischemia/reperfusion injury via regulation of the gsk-3β/HO-1 signaling pathway, Pharmaceuticals 15 (2021), 1
|
R. Dringen, Metabolism and functions of glutathione in brain, Prog. Neurobiol. 62 (2000) 649-671
|
R. Mao, N. Zong, Y. Hu, et al., Neuronal death mechanisms and therapeutic strategy in ischemic stroke, Neurosci. Bull. 38 (2022) 1229-1247
|
Y. Gursoy-Ozdemir, A. Can, T. Dalkara, Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia, Stroke 35 (2004) 1449-1453
|
S. Xu, J. Lu, A. Shao, et al., Glial cells: Role of the immune response in ischemic stroke, Front. Immunol. 11 (2020), 294
|
H. Chen, H. Yoshioka, G.S. Kim, et al., Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection, Antioxidants Redox Signal. 14 (2011) 1505-1517
|
P. Li, R.A. Stetler, R.K. Leak, et al., Oxidative stress and DNA damage after cerebral ischemia: Potential therapeutic targets to repair the genome and improve stroke recovery, Neuropharmacology 134 (2018) 208-217
|
R. He, Y. Jiang, Y. Shi, et al., Curcumin-laden exosomes target ischemic brain tissue and alleviate cerebral ischemia-reperfusion injury by inhibiting ROS-mediated mitochondrial apoptosis, Mater. Sci. Eng. C Mater. Biol. Appl. 117 (2020), 111314
|
H. Xu, J. Shen, J. Xiao, et al., Neuroprotective effect of cajaninstilbene acid against cerebral ischemia and reperfusion damages by activating AMPK/Nrf2 pathway, J. Adv. Res. 34 (2021) 199-210
|
S. Orellana-Urzua, I. Rojas, L. Libano, et al., Pathophysiology of ischemic stroke: Role of oxidative stress, Curr. Pharmaceut. Des. 26 (2020) 4246-4260
|
R. Kannaiyan, M.K. Shanmugam, G. Sethi, Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer, Cancer Lett. 303 (2011) 9-20
|
Y. Lu, Y. Liu, J. Zhou, et al., Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol, Med. Res. Rev. 41 (2021) 1022-1060
|
ClinicalTrials.gov, A Sub-chronic Evaluation of the Safety of Celastrol in Human Subjects. https://beta.clinicaltrials.gov/study/NCT05494112?distance=50&cond=celastrol&rank=2. (Accessed 25 September 2022)
|
ClinicalTrials.gov, Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility. https://clinicaltrials.gov/ct2/show/NCT05413226?cond=celastrol&draw=2. (Accessed 25 September 2022)
|
M. Li, X. Liu, Y. He, et al., Celastrol attenuates angiotensin II mediated human umbilical vein endothelial cells damage through activation of Nrf2/ERK1/2/Nox2 signal pathway, Eur. J. Pharmacol. 797 (2017) 124-133
|
A.C. Allison, R. Cacabelos, V.R. Lombardi, et al., Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease, Prog. Neuro-Psychopharmacol. Biol. Psychiatry 25 (2001) 1341-1357
|
B.S. Choi, H. Kim, H.J. Lee, et al., Celastrol from 'Thunder God Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease, Neurochem. Res. 39 (2014) 84-96
|
C. Cleren, N.Y. Calingasan, J. Chen, et al., Celastrol protects against MPTP-and 3-nitropropionic acid-induced neurotoxicity, J. Neurochem. 94 (2005) 995-1004
|
M. Jiang, X. Liu, D. Zhang, et al., Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33/ST2 axis-mediated microglia/macrophage M2 polarization, J. Neuroinflammation 15 (2018), 78
|
D.-D. Liu, P. Luo, L. Gu, et al., Celastrol exerts a neuroprotective effect by directly binding to HMGB1 protein in cerebral ischemia-reperfusion, J. Neuroinflammation 18 (2021), 174
|
J. Cao, L. Dong, J. Luo, et al., Supplemental N-3 polyunsaturated fatty acids limit A1-specific astrocyte polarization via attenuating mitochondrial dysfunction in ischemic stroke in mice, Oxid. Med. Cell. Longev. 2021 (2021), 5524705
|
R. Verma, C.G. Cronin, J. Hudobenko, et al., Deletion of the P2X4 receptor is neuroprotective acutely, but induces a depressive phenotype during recovery from ischemic stroke, Brain Behav. Immun. 66 (2017) 302-312
|
D. Liu, M. Zhang, X. Rong, et al., Potassium 2-(1-hydroxypentyl)-benzoate attenuates neuronal apoptosis in neuron-astrocyte co-culture system through neurotrophy and neuroinflammation pathway, Acta Pharm. Sin. B 7 (2017) 554-563
|
B. Zhou, Y.-X. Zuo, R.-T. Jiang, Astrocyte morphology: Diversity, plasticity, and role in neurological diseases, CNS Neurosci. Ther. 25 (2019) 665-673
|
M.V. Sofroniew, Astrocyte reactivity: subtypes, states, and functions in CNS innate immunity, Trends Immunol. 41 (2020) 758-770
|
S. Jiang, C. Deng, J. Lv, et al., Nrf2 weaves an elaborate network of neuroprotection against stroke, Mol. Neurobiol. 54 (2017) 1440-1455
|
T.W. Kensler, N. Wakabayashi, S. Biswal, Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway, Annu. Rev. Pharmacol. Toxicol. 47 (2007) 89-116
|
J. Gao, Y. Zhang, X. Liu, et al., Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives, Theranostics 11 (2021) 7199-7221
|
J. Li, J. Hao, Treatment of neurodegenerative diseases with bioactive components of Tripterygium wilfordii, Am. J. Chin. Med. 47 (2019) 769-785
|
T.W. Corson, C.M. Crews, Molecular understanding and modern application of traditional medicines: triumphs and trials, Cell 130 (2007) 769-774
|
M. De Angelis, S.C. Schriever, E. Kyriakou, et al., Detection and quantification of the anti-obesity drug celastrol in murine liver and brain, Neurochem. Int. 136 (2020), 104713
|
M. Chen, M. Liu, Y. Luo, et al., Celastrol protects against cerebral ischemia/reperfusion injury in mice by inhibiting glycolysis through targeting HIF-1β/PDK1 axis, Oxid. Med. Cell. Longev. 2022 (2022), 7420507
|
C. Wang, H. Wan, M. Li, et al., Celastrol attenuates ischemia/reperfusion-mediated memory dysfunction by downregulating AK005401/MAP3K12, Phytomedicine 82 (2021), 153441
|
Z. Liu, M. Chopp, Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke, Prog. Neurobiol. 144 (2016) 103-120
|
I. Lopez-Fabuel, J. Le Douce, A. Logan, et al., Complex I assembly into supercomplexes determines differential mitochondrial ROS production in neurons and astrocytes, Proc. Natl. Acad. Sci. U. S. A. 113 (2016) 13063-13068
|
N.A. Boase, S. Kumar, NEDD4: The founding member of a family of ubiquitin-protein ligases, Gene 557 (2015) 113-122
|
S. Kumar, K.F. Harvey, M. Kinoshita, et al., cDNA cloning, expression analysis, and mapping of the mouse Nedd4 gene, Genomics 40 (1997) 435-443
|
X. Ding, J. Jo, C.Y. Wang, et al., The Daam2-VHL-Nedd4 axis governs developmental and regenerative oligodendrocyte differentiation, Genes Dev. 34 (2020) 1177-1189
|
H.E. Hsia, R. Kumar, R. Luca, et al., Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth, Proc. Natl. Acad. Sci. U. S. A. 111 (2014) 13205-13210
|
J. Drinjakovic, H. Jung, D.S. Campbell, et al., E3 ligase Nedd4 promotes axon branching by downregulating PTEN, Neuron 65 (2010) 341-357
|
Y.D. Kwak, B. Wang, J.J. Li, et al., Upregulation of the E3 ligase NEDD4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration, J. Neurosci. 32 (2012) 10971-10981
|
J. Lackovic, J. Howitt, J.K. Callaway, et al., Differential regulation of Nedd4 ubiquitin ligases and their adaptor protein Ndfip1 in a rat model of ischemic stroke, Exp. Neurol. 235 (2012) 326-335
|
S. Haouari, P. Vourc'h, M. Jeanne, et al., The roles of NEDD4 subfamily of HECT E3 ubiquitin ligases in neurodevelopment and neurodegeneration, Int. J. Mol. Sci. 23 (2022), 3882
|
L. Gao, H.-J. Wang, C. Tian, et al., Skeletal muscle Nrf2 contributes to exercise-evoked systemic antioxidant defense via extracellular vesicular communication, Exerc. Sport Sci. Rev. 49 (2021) 213-222
|
B.J. Saeedi, K.H. Liu, J.A. Owens, et al., Gut-resident Lactobacilli activate hepatic Nrf2 and protect against oxidative liver injury, Cell Metabol. 31 (2020) 956-968
|
L. Kong, J. Deng, X. Zhou, et al., Sitagliptin activates the p62-Keap1-Nrf2 signalling pathway to alleviate oxidative stress and excessive autophagy in severe acute pancreatitis-related acute lung injury, Cell Death Dis.12 (2021), 928
|
A. Saunders, E.Z. Macosko, A. Wysoker, et al., Molecular diversity and specializations among the cells of the adult mouse brain, Cell 174 (2018) 1015-1030.e16
|
S.M. Boas, K.L. Joyce, R.M. Cowell, The NRF2-dependent transcriptional regulation of antioxidant defense pathways: relevance for cell type-specific vulnerability to neurodegeneration and therapeutic intervention, Antioxidants 11 (2021), 8
|
T. Nakayama, K. Okimura, J. Shen, et al., Seasonal changes in NRF2 antioxidant pathway regulates winter depression-like behavior, Proc. Natl. Acad. Sci. U. S. A. 117 (2020) 9594-9603
|
C. Zhang, M. Zhao, B. Wang, et al., The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson's disease, Redox Biol. 47 (2021),102134
|
W. Gong, Z. Chen, Y. Zou, et al., CKIP-1 affects the polyubiquitination of Nrf2 and Keap1 via mediating Smurf1 to resist HG-induced renal fibrosis in GMCs and diabetic mice kidneys, Free Radic. Biol. Med. 115 (2018) 338-350
|
D.J. McIntosh, T.S. Walters, I.J. Arinze, et al., Arkadia (RING finger protein 111) mediates sumoylation-dependent stabilization of Nrf2 through K48-linked ubiquitination, Cell. Physiol. Biochem. 46 (2018) 418-430
|
K. Hochrainer, Protein modifications with ubiquitin as response to cerebral ischemia-reperfusion injury, Transl. Stroke Res. 9 (2018) 157-173
|